The location of a lung nodule is one of several factors that directly influence how likely it is to be cancerous, how easily it can be biopsied, and what treatment options are on the table if it turns out to be malignant. A nodule sitting in the upper lobe of the lung carries a higher probability of cancer than the same-sized nodule in a lower lobe, and a nodule hugging a lung fissure is almost certainly benign. Location is woven into the risk calculators that doctors use to decide whether to watch a nodule, biopsy it, or move straight to surgery, and it shapes outcomes at every stage from detection through treatment.
Why Upper Lobe Nodules Raise More Concern
When radiologists and pulmonologists evaluate a lung nodule found on a CT scan, they look at a cluster of features: size, shape, density, the patient’s age, smoking history, and where in the lung the nodule sits. A large screening study published in the New England Journal of Medicine found that upper-lobe location was an independent predictor of cancer, alongside factors like older age, larger nodule size, spiculated edges, and a family history of lung cancer.1PubMed Central. Probability of cancer in pulmonary nodules detected on first screening CT That study’s risk model, known as the Brock model (or PanCan model), is one of the most widely validated tools used to estimate the chance that a nodule is malignant, and upper-lobe location is baked into its formula.
The reason upper lobes are overrepresented in lung cancer has to do with airflow and carcinogen exposure. Inhaled particles, including cigarette smoke, tend to deposit preferentially in the upper portions of the lung because of the way air distributes during normal breathing. Over decades of exposure, those regions accumulate more damage. This pattern is strong enough that a nodule discovered in someone’s upper lobe during screening gets treated with slightly more suspicion than an identical nodule in the lower lobe, even when every other characteristic is the same.
Perifissural Nodules Are Almost Never Cancer
On the other end of the risk spectrum, some nodules can be largely dismissed based on where they sit. Perifissural nodules are small, solid nodules that attach directly to a lung fissure, the thin membrane that separates the lobes. They tend to have a smooth, lens-shaped or triangular appearance. These nodules are overwhelmingly intrapulmonary lymph nodes, not tumors.
A study tracking over 1,200 noncalcified nodules found that about one in five qualified as perifissural, and none of those turned out to be cancer over roughly four and a half years of follow-up.2PubMed Central. Incidental perifissural nodules on routine chest computed tomography: lung cancer or not? A separate study specifically investigated whether rapid growth in perifissural nodules might signal malignancy. It didn’t. None of the perifissural nodules in that study were malignant either, and one that was surgically removed turned out to be a lymph node.3PubMed. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy
This is practical knowledge that can spare you a lot of anxiety. If your radiology report describes a small solid nodule sitting right against a fissure with a smooth, triangular shape, current guidelines generally recommend either no follow-up or a single short-term check rather than the more aggressive surveillance schedule applied to other nodules. Many updated lung nodule management protocols now specifically carve out perifissural nodules as a low-risk category.
Central Versus Peripheral Nodules and Cancer Type
Where a nodule sits along the center-to-periphery axis of the lung also matters, partly because different types of lung cancer favor different zones. Squamous cell carcinoma has traditionally been associated with the central airways, while adenocarcinoma, now the most common form of lung cancer worldwide, more often appears in the periphery. But the relationship is not absolute, and the exceptions carry real clinical significance.
A study comparing adenocarcinomas in central versus peripheral locations found that the two groups differed under the microscope. Central adenocarcinomas showed more of a glandular growth pattern and less of the slow-spreading lepidic pattern that tends to carry a better prognosis.4PubMed Central. Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations In plain terms, the same broad cancer type can behave more aggressively when it grows near the center of the lung. This has implications for how confidently a doctor can predict outcomes based on a pathology report alone.
Meanwhile, squamous cell carcinoma is increasingly being found in peripheral locations, not just the central airways where textbooks placed it for decades. One study comparing peripheral and central squamous cell carcinomas found differences in protein expression between the two groups, suggesting they may not be biologically identical.5Journal of Pathology and Translational Medicine. Peripheral type squamous cell carcinoma of the lung: clinicopathologic characteristics in comparison to the central type The upshot for patients is that the old rule of thumb, where squamous cell carcinoma equals central and adenocarcinoma equals peripheral, has become more of a tendency than a law.
Pancoast Tumors and the Lung Apex
Some locations create entirely unique clinical syndromes. The most dramatic example is a nodule or mass at the very top of the lung, in the apex, known as the superior sulcus. A tumor growing here can invade the chest wall and compress the nerves and blood vessels that pass through the narrow space at the top of the rib cage. The resulting constellation of symptoms, severe shoulder and arm pain radiating down the inside of the arm, weakness or wasting of the hand muscles, and a drooping eyelid with a constricted pupil on the same side, is called Pancoast-Tobias syndrome.6PubMed Central. Pancoast tumors: characteristics and preoperative assessment
These tumors are often diagnosed late because the initial shoulder pain gets attributed to orthopedic problems. By the time the diagnosis is made, the tumor has usually invaded the chest wall, the brachial plexus nerve bundle, or nearby vertebrae. Treatment typically involves chemotherapy and radiation before surgery, and the surgical approach itself is far more complex than a standard lung cancer operation because the surgeon has to navigate around major nerves and blood vessels at the thoracic inlet.7PubMed Central. Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment A nodule discovered anywhere else in the lung almost never produces this particular set of symptoms. Location alone creates the entire clinical picture.
How Location Affects Biopsy Risk
When a nodule needs to be sampled, its position in the lung shapes both the choice of technique and the risk of complications. The most common complication of a needle biopsy through the chest wall is a pneumothorax, where air leaks into the space around the lung and causes partial collapse. The deeper a nodule sits from the outer surface of the lung, the higher the chance of this happening, because the needle has to travel through more lung tissue, puncturing more air-filled structures along the way. A study examining risk factors for biopsy-related pneumothorax found that the distance from the pleural surface was strongly associated with the complication, with the odds climbing steeply for each additional centimeter of depth. The presence of emphysema roughly tripled the risk on top of that.8PubMed Central. Assessment of Independent Risk Factors of Developing Pneumothorax During Percutaneous Core Needle Lung Biopsy: Focus on Lesion Depth
For centrally located nodules, a needle through the chest wall often is not feasible at all, and doctors turn to bronchoscopy instead, threading a scope through the airways to reach the lesion from the inside. Newer techniques like electromagnetic navigation bronchoscopy use GPS-like tracking to guide instruments to peripheral nodules that are too far down the airway tree to reach with a standard scope. But here too, location creates challenges. A study measuring how much nodules move with breathing during these procedures found that lower-lobe nodules shifted significantly more than upper-lobe nodules, with the average displacement across all lesions being nearly 18 millimeters.9Chest. The effect of respiratory motion on pulmonary nodule location during electromagnetic navigation bronchoscopy That degree of movement can mean the difference between the biopsy instrument hitting the nodule or missing it entirely, which partly explains why diagnostic yields for lower-lobe nodules tend to be lower with navigation bronchoscopy.
Radiation Therapy and the Danger of Central Tumors
If a lung nodule turns out to be an early-stage cancer and the patient cannot undergo surgery, stereotactic body radiation therapy (SBRT) is the most common alternative. SBRT delivers highly focused, high-dose radiation over a few sessions. It works well for peripheral tumors, but its safety profile changes substantially when the target sits near the center of the chest.
Tumors classified as “ultracentral,” meaning they directly touch or invade a major airway or large blood vessel, carry a dramatically higher complication rate when treated with SBRT. One study comparing outcomes across peripheral, central, and ultracentral tumors found that the rate of moderate-or-worse side effects at two years was roughly 8 times higher for ultracentral tumors than for peripheral ones. One patient with an ultracentral tumor developed fatal respiratory failure.10PubMed Central. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors The problem is that the major airways and blood vessels near the center of the chest are more sensitive to radiation damage than peripheral lung tissue, and delivering the high per-fraction doses that make SBRT effective also concentrates the risk of serious injury to those structures.
This is an area of active debate among radiation oncologists. Some centers still treat ultracentral tumors with SBRT using modified dose schedules that spread the radiation over more sessions. Others default to conventionally fractionated radiation, which delivers smaller doses over several weeks, accepting slightly less tumor control in exchange for lower toxicity. The decision hinges almost entirely on the nodule’s position relative to central structures.
Surgical Planning and Nodule Depth
Surgery is the standard treatment for most early-stage lung cancers, and here again, location is a dominant factor. A nodule sitting right beneath the lung surface, close to the pleura, can often be removed with a wedge resection, which takes out a small, pie-shaped piece of lung tissue. Deeper nodules that sit farther from the surface are harder to reach with a wedge and more likely to end up with inadequate margins, meaning cancer cells may remain at the edge of the removed tissue.
A large study comparing different types of limited lung resections found that for nodules located away from the pleural surface, segmentectomy and subsegmentectomy achieved adequate surgical margins far more reliably than wedge resection. Among nodules that were not close to the surface, wedge resection achieved adequate margins only about 56% of the time, compared to roughly 80% for the more anatomically precise approaches. The study also found that about two-thirds of patients who underwent segmentectomy or subsegmentectomy would not have been good candidates for wedge resection.11PubMed. Sublobar resection for small-sized non-small cell lung cancer: A comprehensive comparison between subsegmentectomy, segmentectomy and wedge resection In practical terms, a small cancer near the lung surface may qualify for the simplest and quickest surgery, while an identical cancer buried deeper in the lobe demands a more extensive operation with a longer recovery.
Ground-Glass Nodules and Why Their Location Gets Extra Scrutiny
Not all lung nodules are solid. Ground-glass nodules, which appear as hazy patches on CT that don’t completely block the underlying lung tissue from view, have become increasingly common findings as CT scanning has grown more sensitive. These nodules are often preinvasive or early-stage adenocarcinomas, and their management has become a subspecialty unto itself.
Location turns up as a risk factor here too. A study using high-resolution CT to evaluate ground-glass nodules found that nodule location, along with maximum diameter and the relationship of the nodule to nearby blood vessels, was independently associated with the likelihood of the nodule being or becoming lung adenocarcinoma.12PubMed. Quantitative parameters of HRCT target scan to predict the risk of lung adenocarcinoma based on the detection of lung ground-glass nodules Separately, research using PET/CT scanning to assess ground-glass nodules also identified lesion location as an independent predictor of high-risk disease in invasive lung adenocarcinoma.13PubMed Central. The role of 18F-FDG PET/CT in identifying risk factors for ground-glass nodules in invasive lung adenocarcinoma The consistency across different imaging modalities reinforces that where a ground-glass nodule sits is not an incidental detail but a meaningful input when deciding whether to keep watching or intervene.
Location Blindness in Detection Technology
Even with advances in imaging, some locations are harder to spot nodules in than others, and this applies to both human readers and artificial intelligence. A phantom study (using a model chest with nodules of known size and position) compared the sensitivity of radiology trainees and an AI-based computer-aided detection system. Both humans and AI detected peripheral nodules far more reliably than central ones. The AI system’s sensitivity dropped sharply for nodules in the inner third of the lung, falling to under 10% for central nodules compared to 64% for peripheral ones.14PubMed Central. Performance of an AI based CAD system in solid lung nodule detection on chest phantom radiographs compared to radiology residents and fellow radiologists
The reason is straightforward: central nodules overlap with the heart, great vessels, and mediastinal structures on chest X-rays, making them harder to distinguish from normal anatomy. This is one reason CT scanning, which eliminates that overlap by producing cross-sectional images, is the preferred tool for lung cancer screening rather than chest X-rays. But even on CT, nodules near the hilum (where the major airways and blood vessels enter the lung) can be tricky to separate from lymph nodes and vascular structures. Radiologists reading CT scans routinely pay extra attention to these zones, knowing that lesions there are both more likely to be clinically significant and more likely to be missed on a casual glance.
Benign Conditions and Location-Specific Patterns
Cancer is not the only reason a lung nodule forms, and for many of the benign causes, location provides useful diagnostic clues. Fungal infections, for instance, can create nodules that mimic cancer on imaging. In regions where certain fungi are endemic, like histoplasmosis in the Ohio and Mississippi river valleys or paracoccidioidomycosis in Latin America, granulomatous nodules are common incidental findings. Some fungal infections produce characteristic imaging signs, such as the reversed halo sign with nodular margins seen in paracoccidioidomycosis and tuberculosis, that help distinguish them from malignancy.15Radiol Bras. Tomographic assessment of thoracic fungal diseases: a pattern and signs approach
Occupational lung diseases also distribute in location-specific ways. Silicosis and coal workers’ pneumoconiosis classically produce small nodules that concentrate in the upper lobes, while asbestos-related disease tends to affect the lower lobes and the pleura. These distribution patterns are so characteristic that an experienced radiologist can often narrow the diagnosis based on which zones of the lung are involved before any biopsy is performed.16PubMed Central. Occupational Lung Diseases: Spectrum of Common Imaging Manifestations When a doctor asks about your work history and travel history after finding a lung nodule, part of what they’re doing is matching the nodule’s location and appearance to these known patterns to assess whether an infectious or occupational cause is more likely than cancer.
When Multiple Factors Outweigh Location Alone
For all the weight location carries, it is one variable in a multivariable equation. A spiculated, 2-centimeter nodule in the lower lobe of a 70-year-old smoker is far more worrying than a smooth, 4-millimeter nodule in the upper lobe of a 35-year-old nonsmoker, even though the second nodule sits in the higher-risk zone. Risk models integrate location alongside size, density, edge characteristics, patient age, and smoking status, and any one of those can override the signal from location in a given case.
What makes location distinctive is how broadly it influences the clinical pathway. It changes the probability estimate at the point of discovery, the choice of biopsy technique if tissue is needed, the type of surgery if the nodule is malignant, the safety of radiation if surgery is not an option, and even the likelihood that the nodule gets found in the first place. Few other nodule characteristics touch every stage of the decision-making process the way location does. So while a doctor would never call a nodule cancerous or benign based on location alone, they would also never ignore it.